# BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS

> **NCT02505516** · EARLY_PHASE1 · COMPLETED · sponsor: **UFUOMA MILLER FAKPOR** · enrollment: 150 (actual)

## Conditions studied

- Bladder Cancer
- Diabetes

## Interventions

- **OTHER:** metformin

## Key facts

- **NCT ID:** NCT02505516
- **Lead sponsor:** UFUOMA MILLER FAKPOR
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2014-01
- **Final completion:** 2014-02
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2015-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02505516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02505516, "BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02505516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*